EVER is down -17.26% during regular trading, falling to $18.89 from Friday's $22.83 close. The decline extends a multi-session slide from roughly $24.47 on Sept. 15, with the stock near the lows intraday.

KPLT is trading down -8.84% to $8.04 during the regular session, extending Monday's -7.16% slide from $9.50 to $8.82. Primary catalyst: a Form S-3 shelf registration filed Sept 15, 2026, signaling potential new share issuance and stoking dilution concerns.

QNST is down -14.31% intraday, sliding from a prior close of $17.26 to about $14.79 during the regular session, on elevated volume. The decline extends a sustained slide — the stock was already off roughly -16% over the past month and has shed about -6.6% over the prior week.

The selected price target is $1.00 , a psychological milestone and the level typically required to satisfy Nasdaq's minimum bid price listing rule. Silexion is a clinical-stage biotech advancing SIL204, an RNA interference (RNAi) therapy for KRAS-driven pancreatic cancer, with a Phase 2/3 trial approved in Israel and Germany.

The central question is whether VerifyMe, Inc. (VRME) can climb to a $3 price target , roughly double its most recent closing level. The strongest bullish catalyst is a pending reverse merger with OpenWorld Ltd, a blockchain and real-world asset (RWA) tokenization firm, paired with a planned dual Nasdaq and Figure OPEN on-chain listing.

CLDX is down -17.26% to $31.35 intraday, versus a prior-session close of $37.89. The decline follows a deeper -20%+ premarket drop, driven by a classic "sell-the-news" reaction.

VRME is trading down -32.61% to roughly $0.93 during the regular session, reversing from Monday's close of $1.38. The drop follows Monday's +73% surge (from $0.795 to $1.38) on record volume of roughly 60M shares, driven by merger speculation.

ONON is up +13.14%, rallying from a prior close of $27.32 to about $30.91 in Tuesday's session after starting higher in premarket. The primary catalyst was the company's Investor Day, where it unveiled 2029 targets including at least CHF 5.6 billion in net sales and a 22% adjusted EBITDA margin.

ALL fell -5.15% to about $230.35 during Tuesday's regular session, extending a multi-day slide and touching its lowest level since June. The decline pushed Allstate into the day's top US decliners as investors reacted to mounting catastrophe losses.

NYT dropped about -5.61% to roughly $66.57 intraday, down from a $70.53 prior close, with the slide unfolding during regular trading after a modest premarket gain. Primary catalyst: the U.S. Department of Justice filed a statement of interest backing OpenAI and Microsoft, arguing that training AI on copyrighted works can qualify as fair use in NYT's copyright suit.

LPLA is trading down -7.33% intraday to roughly $307.89, versus a prior close of $332.26, with the drop unfolding during the regular session. The decline was driven primarily by a technical breakdown rather than company-specific news, as the stock broke below its ~$333 weekly support level.

WGS is down about -9.33% intraday during regular trading hours, sliding from a $97.83 prior close to roughly $88.70. The primary catalyst is mounting concern over the CMS laboratory fee schedule proposal, which analysts warned could create confusion across genomics diagnostics names.

VKTX is up +27.53% to $38.40, surging in premarket trading and extending gains into the regular session after a positive VK2735 readout. The primary catalyst: top-line results from the VK2735 maintenance study showed patients retained up to 97% of weight loss on every-other-week dosing and up to 90% on monthly dosing, versus 61% for placebo.

SCHW fell -5.05% during regular market hours, sliding from a $106.88 prior close to roughly $101.48 in morning trading. The move reflects a broad risk-off session across financials, not a company-specific headline.

AIMG is a newly launched, passively managed ETF that tracks the BITA AI Magnificent 10 Select Index, holding 10 equally weighted equities across the artificial intelligence (AI) value chain. The fund is non-diversified and concentrated in the Semiconductors and Semiconductor Equipment industry, spanning compute and accelerators, custom ASICs, foundries, memory, networking, photonics, and physical AI systems.

Bloom Energy (BE) shares have climbed roughly 35.5% over the last 30 days, from a $201.45 close on Aug. 21, 2026, to $272.89 on Sept. 21, 2026. The rally has been fueled by surging AI data center electricity demand, record second-quarter results, and upwardly revised full-year guidance.

META climbed roughly 34.8% over the last 30 days, rising from about $549.90 to $741.245 per share. The rally was powered by strong early adoption of Muse, Meta's new personal AI agent, which surged to the top of Apple's App Store charts.

AMD shares climbed roughly 30% over the trailing 30 days, from a close near $473 to about $615, pushing the company's market value above $1 trillion for the first time. The rally was powered by surging AI-driven demand for data-center CPUs and GPUs, led by the EPYC server line and the Instinct MI400 and Helios accelerators.

Intel shares climbed roughly 35% over the 30-day period ending in late September 2026, rising from a closing price near $90 to about $121.78. The advance was fueled by renewed AI-server CPU demand, a reported SK Hynix manufacturing partnership, and a wave of Wall Street upgrades.

NIO's American depositary shares fell roughly 20.7% over the last 30 days, declining from a closing price of $4.63 on August 21 to $3.67 on September 21. The pullback extended a longer downtrend, with the stock down approximately 27% over the last quarter, from about $5.05 in late June.